Target intelligence / Profile preview

Plasminogen mRNA (PLG mRNA)

Target: PLG mRNA
Molecular classification: mRNA, transcript

Overview

Plasminogen mRNA is the transcript produced from the PLG gene that encodes the precursor protein plasminogen, mainly synthesized in the liver and found in plasma. Plasminogen is proteolytically activated to plasmin, a serine protease responsible for fibrin degradation (fibrinolysis) and essential for wound healing, cell migration, inflammation, and resolution of blood clots. Expression of plasminogen mRNA has been detected in various tissues, highlighting its broad biological relevance. Clinical interventions target the protein or its activators/inhibitors, not the mRNA transcript itself.

Other names: PlasminogenPLGPLG mRNAPlasmin precursorPlg gene

Mechanism of action

Drugs promote conversion of plasminogen to plasmin to dissolve blood clots (tPA, urokinase); Inhibitors block activation for antifibrinolytic effect (tranexamic acid)

Biological functions

Encodes plasminogen for synthesis of plasmin (fibrinolytic enzyme)Gene expression biomarker

Disease associations

Cardiovascular disease (thrombosis, embolism)InflammationCancerWound healing and immune response

Safety considerations

Manipulation of gene expression or mRNA widely affects tissue physiology; not a direct therapeutic approachFor drugs targeting the plasminogen protein: risk of bleeding, hypotension, allergic reactions, therapeutic failure in low plasminogen expression

Interacting drugs

Tissue plasminogen activator (tPA, alteplase, reteplase, tenecteplase)

4 more in the full profile.

Biomarkers

Quantification of plasminogen mRNA is sometimes used to study gene expression in tissues related to clotting, inflammation, or oncologyNot a clinical biomarker for therapy selection (protein levels and activity are standard instead)

Beyond the preview

Go deeper on Plasminogen mRNA (PLG mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasminogen mRNA (PLG mRNA).

Explore the full profile